MEI Pharma, Inc. (NASDAQ:MEIP) Receives Average Recommendation of “Hold” from Analysts
Shares of MEI Pharma, Inc. (NASDAQ:MEIP – Get Free Report) have been given an average rating of “Hold” by the six research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has issued a buy recommendation […]
More Stories
Short Interest in Primech Holdings Ltd. (NASDAQ:PMEC) Drops By 20.3%
Primech Holdings Ltd. (NASDAQ:PMEC – Get Free Report) was the target of a significant drop in short interest during the...
Richmond Mutual Bancorporation, Inc. (NASDAQ:RMBI) Short Interest Down 20.8% in November
Richmond Mutual Bancorporation, Inc. (NASDAQ:RMBI – Get Free Report) was the target of a large decrease in short interest in...
iShares MSCI Japan Value ETF (NASDAQ:EWJV) Short Interest Down 34.6% in November
iShares MSCI Japan Value ETF (NASDAQ:EWJV – Get Free Report) was the recipient of a large decline in short interest...
Financial Comparison: Valuence Merger Corp. I (VMCA) versus The Competition
Earnings & Valuation This table compares Valuence Merger Corp. I and its peers gross revenue, earnings per share and valuation....
Short Interest in iShares 1-5 Year Investment Grade Corporate Bond ETF (NASDAQ:IGSB) Drops By 34.7%
iShares 1-5 Year Investment Grade Corporate Bond ETF (NASDAQ:IGSB – Get Free Report) was the recipient of a large decline...
Aston Martin Lagonda Global Holdings plc (OTCMKTS:ARGGY) Sees Large Decrease in Short Interest
Aston Martin Lagonda Global Holdings plc (OTCMKTS:ARGGY – Get Free Report) was the recipient of a significant decline in short...